Laboratoires üma Raises €4M Seed to Scale Women's Midlife Health Range

Laboratoires üma Secures €4M Seed Round

French independent laboratory Laboratoires üma has raised €4 million in Seed funding, according to a funding announcement dated September 18, 2026. The round was led by The Moon Venture, with participation from Kima Ventures, Ring Capital and Le DealClub.

What the Company Does

Laboratoires üma is a French independent laboratory dedicated to women's midlife health. Its range focuses on hormone-free, naturally derived dietary supplements formulated for premenopause, menopause and post-menopause.

The company positions itself as a pioneer of micronutrition and phytotherapy in this category. Its product line includes:

• Harmonie Daily
• Iconique Collagène
• Oh La La!

Products are sold direct-to-consumer as well as through partner pharmacies, giving the brand both a digital channel and a physical retail footprint.

Traction to Date

Founded around 2023, Laboratoires üma reports strong growth. The company says around 60,000 women have used its range, and it holds a 4.58/5 rating across more than 5,000 verified reviews. Those figures point to an established consumer base and a repeatable feedback loop at an early stage of the company's development.

The Round at a Glance

• Company: Laboratoires üma
• Round type: Seed
• Amount raised: €4,000,000
• Currency: EUR
• Announced date: September 18, 2026
• Lead investor: The Moon Venture
• Additional investors: Kima Ventures, Ring Capital, Le DealClub

Why This Round Matters

The raise places Laboratoires üma among a growing set of European consumer health brands targeting specific life stages rather than broad wellness audiences. By concentrating on women's midlife health — a segment that spans premenopause, menopause and post-menopause — the company addresses a defined need with a clearly framed, hormone-free and naturally derived product proposition.

The combination of direct-to-consumer sales and partner pharmacy distribution gives the brand two routes to market. The pharmacy channel in particular lends credibility in the French market, where consumers frequently seek supplement advice at the counter.

With €4 million in new capital and a syndicate that includes The Moon Venture as lead alongside Kima Ventures, Ring Capital and Le DealClub, the company has the backing to build on the traction it reports: roughly 60,000 women having used its range and a 4.58/5 rating across more than 5,000 verified reviews.

What to Watch

For observers tracking consumer health and women's health categories, Laboratoires üma is a company to monitor. Its positioning at the intersection of micronutrition, phytotherapy and midlife women's health is distinctive, and its dual distribution model — direct-to-consumer plus partner pharmacies — offers a template for scaling in France and potentially beyond.

The Seed round, led by The Moon Venture with Kima Ventures, Ring Capital and Le DealClub participating, provides the resources to expand that model. How the company converts its early user base and review strength into sustained growth will be the key metric to follow.

Summary

Laboratoires üma, a French independent laboratory focused on women's midlife health, has raised €4 million in Seed funding led by The Moon Venture, with Kima Ventures, Ring Capital and Le DealClub participating. The company offers hormone-free, naturally derived dietary supplements for premenopause, menopause and post-menopause, sold direct-to-consumer and through partner pharmacies. Founded around 2023, it reports that around 60,000 women have used its range and holds a 4.58/5 rating across more than 5,000 verified reviews.